×
About 295 results

ALLMedicine™ Arrhythmogenic Right Ventricular Dysplasia Center

Research & Reviews  105 results

Left ventricular fibro-fatty replacement in arrhythmogenic right ventricular dysplasia/...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8135158
Journal of Cardiovascular Magnetic Resonance : Official J... Zghaib T, Te Riele ASJM et. al.

May 21st, 2021 - Left ventricular (LV) fibrofatty infiltration in arrhythmogenic right ventricular (RV) dysplasia/cardiomyopathy (ARVD/C) has been reported, however, detailed cardiovascular magnetic resonance (CMR) characteristics and association with outcomes are...

Diagnosis and treatment of HCV heart diseases.
https://doi.org/10.1080/14779072.2021.1917383
Expert Review of Cardiovascular Therapy; Haykal M, Matsumori A et. al.

Apr 17th, 2021 - Hepatitis C virus (HCV) infection is an important cause of a variety of otherwise unexplained heart diseases and myocardial injury. A high prevalence of HCV infection has been noted in patients with hypertrophic cardiomyopathy, dilated cardiomyopa...

Desmosomal COP9 regulates proteome degradation in arrhythmogenic right ventricular dysp...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159691
The Journal of Clinical Investigation; Liang Y, Lyon RC et. al.

Apr 16th, 2021 - Dysregulated protein degradative pathways are increasingly recognized as mediators of human disease. This mechanism may have particular relevance to desmosomal proteins that play critical structural roles in both tissue architecture and cell-cell ...

Electroanatomic voltage mapping and characterisation imaging for "right ventricle arrhy...
https://doi.org/10.1007/s10554-021-02221-3 10.1016/j.jacc.2004.01.029 10.1161/01.CIR.0000083725.72693.EA 10.1016/S0735-1097(01)01625-4 10.1016/j.jacc.2007.11.027 10.1161/CIRCEP.110.959957 10.1016/j.hrthm.2015.09.023 10.1161/01.CIR.88.3.915 10.1161/CIRCEP.109.904763 10.1161/CIRCEP.110.960740 10.1161/CIRCEP.111.963066 10.1161/CIRCEP.111.968677 10.1161/01.CIR.103.6.913 10.1016/j.hrthm.2010.09.088 10.1159/000070672 10.1046/j.1540-8167.2004.03429.x 10.1161/01.CIR.94.5.983 10.1016/S0735-1097(97)00332-X 10.1016/S0735-1097(01)01625-4 10.1046/j.1540-8167.2005.40710.x 10.1016/S1547-5271(08)00029-5 10.1111/j.1540-8159.2007.00703.x 10.1093/eurheartj/ehq025 10.1093/eurheartj/ehaa003 10.1161/CIRCULATIONAHA.104.486977 10.1016/S1054-8807(01)00067-9 10.1093/eurheartj/14.5.717 10.1016/j.jacc.2008.11.017 10.1093/europace/euw062 10.1161/CIRCEP.111.974881 10.1161/CIRCEP.111.964635 10.1161/CIRCEP.115.003366 10.1016/j.cardiores.2005.03.005 10.1016/j.yjmcc.2010.07.012 10.1161/01.CIR.100.15.1660 10.1016/S0735-1097(02)02494-4 10.1161/01.CIR.0000118467.53182.D1 10.1016/S0735-1097(02)01888-0 10.1046/j.1542-474X.2003.08106.x 10.1161/01.CIR.0000088781.99943.95 10.1016/j.hrthm.2016.12.001 10.1016/j.hrthm.2018.03.019 10.1161/CIRCEP.115.003220 10.1161/CIRCEP.117.005053 10.1016/j.hrthm.2016.07.025 10.1161/CIRCEP.119.007500 10.1161/CIRCULATIONAHA.119.042423 10.1093/europace/euz167 10.1002/joa3.12308 10.1093/europace/euy304 10.1007/s12265-008-9080-7 10.1016/j.jacc.2008.05.038 10.1016/j.jacc.2008.11.052
The International Journal of Cardiovascular Imaging; Zoppo F, Gagno G et. al.

Mar 25th, 2021 - Three-dimensional (3D) reconstruction by means of electroanatomic mapping (EAM) systems, allows for the understanding of the mechanism of focal or re-entrant arrhythmic circuits along with pacing techniques. However, besides this conventional use,...

Long-Term Outcome After Ventricular Tachycardia Ablation in Nonischemic Cardiomyopathy:...
https://doi.org/10.1161/CIRCEP.119.008307
Circulation. Arrhythmia and Electrophysiology; Okubo K, Gigli L et. al.

Jul 14th, 2020 - In patients with an ischemic cardiomyopathy (ICM), the combination of late potential (LP) abolition and postprocedural ventricular tachycardia (VT) noninducibility is known to be the desirable end point for a successful long-term outcome after VT ...

see more →

Guidelines  1 results

Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guide...
https://doi.org/10.1016/j.cardfail.2009.01.006
Journal of Cardiac Failure; Hershberger RE, Lindenfeld J et. al.

Mar 4th, 2009 - Substantial progress has been made recently in understanding the genetic basis of cardiomyopathy. Cardiomyopathies with known genetic cause include hypertrophic (HCM), dilated (DCM), restrictive (RCM), arrhythmogenic right ventricular dysplasia/ca...

see more →

Clinicaltrials.gov  3 results

Blockade of the Renin-angiotensin-aldosterone System in Patients With ARVD
https://clinicaltrials.gov/ct2/show/NCT03593317

Jul 20th, 2018 - Arrhythmogenic right ventricular dysplasia (ARVD) is a rare cardiomyopathy characterized by the progressive replacement of cardiomyocytes by fatty and fibrous tissue in the right ventricle (RV). These infiltrations lead to cardiac electrical insta...

Isoproterenol Challenge to Detect Arrhythmogenic Right Ventricular Cardiomyopathy
https://clinicaltrials.gov/ct2/show/NCT00083395

Mar 4th, 2008 - Arrhythmogenic right ventricular cardiomyopathy (ARVC) formerly referred to as arrhythmogenic right ventricular dysplasia (ARVD) is a familial hetergenous clinical and molecular disease characterized by dilatation and dysfunction of the right vent...

Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases
https://clinicaltrials.gov/ct2/show/NCT00221832

Molecular genetic screening in patients with: supraventricular ventricular arrhythmia syncopes of unknown origin and/or suspicion of an arrhythmogenic origin family members of patients with sudden cardiac death and aborted sudden cardiac death Exa...

see more →

News  7 results

Sudden Death in Hypertrophic Cardiomyopathy Usually Not at Exertion: Registry
https://www.medscape.com/viewarticle/868501

Sep 7th, 2016 - ROME, ITALY — Most cases of sudden cardiac death in a pathology-registry study of people with hypertrophic cardiomyopathy (HCM) occurred during rest or sleep, not during exercise[1]. Notably, individuals who died on the playing field—mostly on the...

Sudden Death in Hypertrophic Cardiomyopathy Usually Not at Exertion: Registry
https://www.staging.medscape.com/viewarticle/868501

Sep 7th, 2016 - ROME, ITALY — Most cases of sudden cardiac death in a pathology-registry study of people with hypertrophic cardiomyopathy (HCM) occurred during rest or sleep, not during exercise[1]. Notably, individuals who died on the playing field—mostly on the...

Most ICD Athletes Can Play Sports Without Cardiac Risks
https://www.staging.medscape.com/viewarticle/823062

Apr 3rd, 2014 - WASHINGTON, DC — In the end, it really wasn't much of a debate at all. Two experts, citing similar research, made the case that most athletes with heart problems requiring an implantable cardioverter defibrillator (ICD) should be allowed to partic...

Endurance Exercise and Heart Disease: Look for Clues in the Genes
https://www.medscape.com/viewarticle/806917

Jun 26th, 2013 - There's a lot controversy surrounding the relationship between endurance exercise and heart disease. Smart people debate the issue of causality, the dosage of exercise needed to provoke disease, and many other confounding factors. But one thing we...

#14: Sudden cardiac death in the young: The role of arrhythmogenic right ventricular dysplasia
https://www.medscape.com/viewarticle/801894

Sep 7th, 2012 - This feature requires the newest version of Flash. You can download it here. Dr Samuel Asirvatham joins the show to discuss arrhythmogenic right ventricular dysplasia (ARVD), the second most common cause of death in young athletes after hypertroph...

see more →

Patient Education  2 results see all →